The Laboratory Core provides coordinated, integrated laboratory testing to facilitate each Project and the Clinical Core. Work will be performed at 3 laboratories that are part of the University of Washington Virology Division. The UW Virology Section at Children's Hospital and Regional Medical Center (""""""""UW-CHRMC"""""""") provides HSV culture, HSV-1 and HSV-2 serology, and HIV-1 serology. The Molecular Virology Laboratory recently moved to a large integrated laboratory devoted entirely to molecular diagnostics for viral disease at Fred Hutchinson Cancer Research Center at 1616 Eastlake, adjacent to Dr. Corey's office at FHCRC. Staff at this location (""""""""PCR-FHCRC"""""""") will provide quantitative, real-time, high throughput viral DMA testing for HSV-1, HSV-2 and HIV-1. The HSV Western blot serology and the HSV real-time PCR for HSV DNA detection are state-of-the art tests that were developed in previous years of this Program Project. A rapid, easily performed adaptation of the HSV PCR has been developed over the past 3 years to test for the presence of HSV in the birth canal of pregnant women at labor and delivery. This test is both accurate and rapid and has proven in early validation trials to be performed effectively by staff in a general use, hospitalbased Microbiology Laboratory with results comparable to those achieved in the PCR-FHCRC lab. A major goal of the Laboratory Core is to finalize the parameters for the rapid HSV PCR and to successfully complete the transfer of this test to the UW Microbiology lab for routine use among women entering the labor and delivery suite at the University of Washington Hospital. Our program will develop quality control protocols for the rapid HSV PCR and will provide monitoring and proficiency testing services to assure continued high performance of this test to meet the requirements of Project 2. The third laboratory involved in this Core is Dr. David Koelle's research lab at the FHCRC 1616 Eastlake building. The Koelle lab will perform strain typing for HSV-1 and HSV-2 from either mucosal samples or from viral culture isolates from patients enrolled in Projects 1, 2, and the Clinical Core. This group has unique expertise to provide the most powerful available techniques to detect and identify epidemiologically linked HSV strains. This lab's PCR-based methods maximize sensitivity for minor differences in HSV DNA sequence and also can be applied directly to patient samples thus avoiding the risk of minor mutations developing during viral amplification in culture. The sequencing techniques are continually being refined and have promise for delineating the pace and process of HSV genetic changes, within patients or following transmission, that might affect the natural history of herpes infections. Laboratory Core activities are directed by Larry Corey MD, Rhoda Morrow PhD, David Koelle MD, and MeeiLi Huang, Ph.D;all are internationally recognized for their contributions to developing unique lab tests for HSV and HIV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI030731-22
Application #
8382100
Study Section
Special Emphasis Panel (ZAI1-MMT-M)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
22
Fiscal Year
2012
Total Cost
$322,667
Indirect Cost
$62,949
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Ott, Mariliis; Jing, Lichen; Lorenzo, Lazaro et al. (2017) T-cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis. Pediatr Infect Dis J 36:741-744
Matrajt, Laura; Gantt, Soren; Mayer, Bryan T et al. (2017) Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children. Sci Rep 7:13105
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2017) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect :
Abana, Chike O; Pilkinton, Mark A; Gaudieri, Silvana et al. (2017) Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects. J Immunol 199:3187-3201
Celum, Connie; Hong, Ting; Cent, Anne et al. (2017) Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis 215:907-910
Hensel, Michael T; Peng, Tao; Cheng, Anqi et al. (2017) Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol 91:
Koelle, David M; Norberg, Peter; Fitzgibbon, Matthew P et al. (2017) Worldwide circulation of HSV-2?×?HSV-1 recombinant strains. Sci Rep 7:44084
Gilbert, Peter B; Excler, Jean-Louis; Tomaras, Georgia D et al. (2017) Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One 12:e0176428
Looker, Katharine J; Magaret, Amalia S; May, Margaret T et al. (2017) First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health 5:e300-e309
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2017) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol :

Showing the most recent 10 out of 340 publications